Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

Side Effects of Statins Might Be Overstated: CTT Collaboration

Michael O'Riordan

February 12, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

News Conference News AHA 2024

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Shelley Wood

November 18, 2024

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

News Daily News

Kidney Events High in Older Patients After HF Hospitalization

L.A. McKeown

May 30, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Daily News

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Todd Neale

May 01, 2024

News Daily News

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

L.A. McKeown

February 23, 2024

News Daily News

Niacin, When Broken Down by the Body, Can Spur Inflammation

Caitlin E. Cox

February 22, 2024

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Yael L. Maxwell

June 23, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

Statins in COVID-19: More Signs of Potential Benefit

Todd Neale

February 26, 2021

News Daily News

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Michael O'Riordan

December 21, 2020

News Features

Funding the Future: How Industry Support for CV Trials Could Evolve

Michael O'Riordan

December 17, 2020

Advertisement

Side Effects of Statins Might Be Overstated: CTT Collaboration

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Kidney Events High in Older Patients After HF Hospitalization

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Statins Might Help in HFpEF—Even in the Absence of ASCVD

Efforts to Up PCSK9 Use Still Falling Short, Analysis Finds

Niacin, When Broken Down by the Body, Can Spur Inflammation

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

May 2023 News Roundup

USPSTF: Most Vitamin, Supplement Data Still ‘Inconclusive’ on CVD Benefits

Good News and Bad for High-Intensity Statin Use in ASCVD

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Statins in COVID-19: More Signs of Potential Benefit

ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show

Funding the Future: How Industry Support for CV Trials Could Evolve

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content